Feasibility of Shortening 14‐day Hybrid Therapy While Maintaining an Excellent Helicobacter pylori Eradication Rate
Feasibility of Shortening 14‐day Hybrid Therapy While Maintaining an Excellent Helicobacter pylori Eradication Rate
复制标题
DOI：
10.1111/hel.12113
复制
发表时间：
2014-06
期刊：
影响因子：
4.4
通讯作者：
Jeng‐Yih Wu;P. Hsu;Deng-Chyang Wu;D. Graham;Wen-ming Wang
中科院分区：
文献类型：
--
作者：
Jeng‐Yih Wu;P. Hsu;Deng-Chyang Wu;D. Graham;Wen-ming Wang
对新的有效的幽门螺杆菌根除疗法的需求集中在开发和优化具有优异根除率的方案上，如14天混合疗法。本研究评估了是否可以在保持高根除率的同时减少混合治疗的持续时间，并检查抗生素耐药性对结果的影响。
The need for new effective Helicobacter pylori eradication therapy has focused efforts on the development and optimization of regimens with excellent eradication rates such as 14‐day hybrid therapy. This study evaluated whether the duration of hybrid therapy could be reduced while maintaining a high eradication rate and to examine the effect of antibiotic resistance on outcome.